10:26 AM EST - Ondine Biopharma Corp. : has reported a 2007 loss of $13.2 million, compared with a prior-year loss of $12 million, as sales of its Periowave laser systems to treat gum disease were flat at $1.6 million. Ondine Biopharma Corp.
shares T.OBP are trading unchanged at $0.90.
